PL EN


2015 | 4 | 262-266
Article title

Neuropatia obwodowa w przebiegu chemioterapii na bazie oksaliplatyny u chorych na raka jelita grubego i odbytnicy. Doniesienie wstępne

Content
Title variants
Languages of publication
PL
Abstracts
Contributors
References
  • Zedan AH, Hansen TF, Fex Svenningsen A, et al. Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers. Clin Colorectal Cancer 2014; 13: 73–80.
  • Velasco R, Bruna J, Briani C, et al. Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.J Neurol Neurosurg Psychiatry 2014; 85: 392–398.
  • Park SB, Goldstein D, Krishnan AV, et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 2013; 63: 419–437.
  • Park SB, Lin CS, Krishnan AV, et al. Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility.Oncologist 2011; 16: 708–716.
  • Brani C, Argyriou AA, Izquierdo C, et al. Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study. J Peripher Nerv Sys 2014; 19: 299–306.
  • Argyriou AA, Briani C, Cavaletti G, et al. Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study. Eur J Neurol 2013; 20: 788–794.
  • Lehky TJ, Leonard GD, Wilson RH, et al. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.Muscle Nerve 2004; 29: 387–392.
  • Ewertz M, Qvortrup C, Eckhoff L. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol 2015; 54: 587–591.
  • Argyriou AA, Kyritsis AP, Makatsoris T, et al. Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Manag Res 2014; 6: 135–147.
  • Cersosimo RJ. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 2005; 39: 128–135.
  • Park SB, Goldstein D, Lin CS, et al. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.J Clin Oncol 2009; 27: 1243–1249.
  • Kuwabara S, Ogawara K, Sung JY, et al. Differences in membrane properties of axonal and demyelinating Guillan-Barre syndrome.Ann Neurol 2002; 52: 180–187.
  • Cavaletti G, Tredici G, Petruccioli MG, et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer 2001; 37: 2457–2463.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-81e89dec-4537-4ffb-aa3b-bbad8cf712ec
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.